Interferon alpha-2a biosimilar (Elea)

干扰素α-2a生物类似药 (Elea)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alpha-2a biosimilar (Elea)
Drug Alias Name干扰素α-2a生物仿制药 (Elea)Interferon alfa-2a biosimilar - EleaInterferon α-2a biosimilar - Elear-hu-IFNa2
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionImmunomodulatorsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsNervous System DiseasesNeoplasmsVirus Diseases
Global Approved IndicationsNervous System DiseasesNeoplasmsVirus Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryArgentina
Original Approved Date2015/01/01
Country/TerritoryArgentina
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesElea
China Registration ClassN/A

Develop Information

Active CompaniesElea
Inactive CompaniesN/A
Active IndicationsNervous System DiseasesNeoplasmsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeL03AB04
Related LinksN/A